Nextida® GC
Specific collagen peptide developed by Rousselot for glucose-control applications, taken before meals.
Supplier: Rousselot. Positioned for: Blood sugar, Metabolic & weight, Food & beverage formulation. Company cites a placebo-controlled clinical study in 16 healthy people on post-meal glucose and GLP-1, published in 2024, and a further human study published in 2026.
How to merchandise Nextida® GC
Where it sits
Metabolic health or blood sugar section.
Pair it with
- Fibre supplements
- Chromium
- Cinnamon products
- Meal-replacement shakes
Who asks for it
Shoppers curious about GLP-1 and post-meal blood sugar topics.
On the store floor
- It is a targeted collagen peptide, not a general beauty collagen.
- It has an early human clinical study.
- Anyone on diabetes medication or GLP-1 drugs should speak with their prescriber first.
Display idea
Shelf card explaining that not all collagen is the same, pointing to the specific use on each label.
What a store can say about a product made with Nextida® GC depends on that finished product's own licence or label in your market (for example a Health Canada NPN, US structure/function wording or EU authorised claims), so check it before describing uses.